Profile of obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemia
Brian T Hill, Matt Kalaycio Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA Abstract: Chronic lymphocytic leukemia (CLL) is a hematologic malignancy derived from a clonal population of mature B-lymphocytes characterized by relatively lo...
Main Authors: | Hill BT, Kalaycio M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-08-01
|
Series: | OncoTargets and Therapy |
Online Access: | http://www.dovepress.com/profile-of-obinutuzumab-for-the-treatment-of-patients-with-previously--peer-reviewed-article-OTT |
Similar Items
-
Obinutuzumab treatment in the elderly patient with chronic lymphocytic leukemia
by: Seiter K, et al.
Published: (2015-06-01) -
Clinical role of obinutuzumab in the treatment of naive patients with chronic lymphocytic leukemia
by: Cerquozzi S, et al.
Published: (2015-02-01) -
Targeted treatment for chronic lymphocytic leukemia: clinical potential of obinutuzumab
by: Smolej L
Published: (2014-12-01) -
New developments in the treatment of chronic lymphocytic leukemia: role of obinutuzumab
by: Shah A
Published: (2015-07-01) -
Clinical application of obinutuzumab for treating chronic lymphocytic leukemia
by: Luan C, et al.
Published: (2019-08-01)